Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent expirations
Pharma
Novartis CEO eyes 2026 growth despite record patent cliff
Despite a $4 billion revenue hole from the “largest patent expiry” in Novartis’ history, CEO Vas Narasimhan insisted that Novartis will grow in 2026.
Angus Liu
Feb 4, 2026 2:30pm
Gilead inks Biktarvy settlements with 3 generic drug makers
Oct 7, 2025 7:40am
Fierce Biotech
China biotechs ‘reshaping’ US biopharma: Jefferies report
Jul 14, 2025 2:30pm
JPM25: Takeda touts 6 pipeline assets with big sales potential
Jan 15, 2025 3:17pm
Teva hit with €463M fine over Copaxone misconduct claims in EU
Oct 31, 2024 10:45am
'The Top Line': 2023's exclusivity losses, this week's news
Apr 7, 2023 7:30am
Fierce Biotech
Fierce Biotech
Fierce Biotech
Fierce Biotech
